Promising therapies overshadowed by challenging work environment - Mitarbeiter (anonym) bei Rigel Pharmaceuticals: Mitarbeiterbewertung

1,0
20. Apr. 2026
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The pipeline of upcoming therapies is good

Kontras

The commercial analytics team operates in a challenging and often unsustainable environment. Priorities frequently shift without clear rationale, leading to reactive work cycles and limited ability to execute long-term strategy. There is a consistent gap between leadership expectations and available resources, which results in heavy workloads and a culture where long hours feel normalized. Recognition and constructive feedback are inconsistent, making it difficult for employees to understand how to grow or succeed. Concerns around management practices also impact morale. Experiences across the team suggest that junior employees and consultants are not always supported or treated with the level of respect expected in a healthy work environment. These issues are not isolated and appear to be systemic within parts of the organization.

Mehr Bewertungen zu Rigel Pharmaceuticals entdecken

5,0
30. Sept. 2022
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Fantastic minds, great people, great projects

Kontras

Traffic and location, but none in the company

3,0
17. Juni 2026
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Improving training processes but this has taken years and is still lacking

Kontras

Leadership in MA practices favoritism and objectives/strategies are never communicated clearly. Field MA team does not operate like a team.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle